Skip to main
CL

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive (CL) Analyst Ratings

Based on 16 analyst ratings
Buy
Strong Buy 44%
Buy 38%
Hold 19%
Sell 0%
Strong Sell 0%

Bulls say

Colgate-Palmolive is a global leader in the household and personal care industry, with a strong focus on emerging markets and a diverse product portfolio. Despite inflationary pressures on gross margins, the company has shown sequential top-line progress and has multiple levers in place to mitigate cost pressures. With a sustainable and socially responsible strategy in place, we maintain our positive outlook on the company's future growth potential and reiterate our Outperform rating.

Bears say

Colgate-Palmolive is facing significant inflationary pressure on raw materials and logistics costs, which is expected to negatively impact gross margin for the remainder of the year. Additionally, the slower-than-expected start in the North American market is leading to declining market share in toothpaste, while Hill's Pet Nutrition continues to experience declines due to the discontinuation of private label products, adding to the negative outlook on the stock. The company's involvement in CEO Action for Diversity and Inclusion and sustainability initiatives may have a positive impact in the long term, but near-term headwinds in the industry, such as Unilever's hiring freeze, could limit growth potential.

Colgate-Palmolive (CL) has been analyzed by 16 analysts, with a consensus rating of Buy. 44% of analysts recommend a Strong Buy, 38% recommend Buy, 19% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Colgate-Palmolive (CL) Forecast

Analysts have given Colgate-Palmolive (CL) a Buy based on their latest research and market trends.

According to 16 analysts, Colgate-Palmolive (CL) has a Buy consensus rating as of May 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $95.31, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $95.31, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Colgate-Palmolive (CL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.